drugset
drugset / Trial / NCT04625361

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects

NCT04625361 ↗

Phase 1 Completed 106 enrolled Sunshine Lake Pharma Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The Safety, Tolerability, Pharmacokinetic and Food Effect Study of HEC122505MsOH Tablets in Healthy Subjects

Timeline

Start
2021-01-20
Primary completion
2022-01-06
Completion
2022-01-06

Drugs

EvaluationDrugModalityDoseRoute
Subject HEC122505MsOH Unknown — —

Indications

Parkinson disease